日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/26 | 1,926 | 1,926 | 1,911 | 1,921 | +10 | +0.5% | 3,500 |
| 2022/08/25 | 1,897 | 1,922 | 1,890 | 1,911 | +22 | +1.2% | 4,500 |
| 2022/08/24 | 1,881 | 1,893 | 1,880 | 1,889 | +8 | +0.4% | 2,600 |
| 2022/08/23 | 1,880 | 1,889 | 1,880 | 1,881 | -11 | -0.6% | 1,400 |
| 2022/08/22 | 1,873 | 1,894 | 1,873 | 1,892 | +2 | +0.1% | 1,800 |
| 2022/08/19 | 1,872 | 1,890 | 1,872 | 1,890 | +18 | +1% | 4,500 |
| 2022/08/18 | 1,870 | 1,883 | 1,870 | 1,872 | -11 | -0.6% | 2,300 |
| 2022/08/17 | 1,863 | 1,883 | 1,863 | 1,883 | +13 | +0.7% | 5,100 |
| 2022/08/16 | 1,862 | 1,877 | 1,859 | 1,870 | +4 | +0.2% | 4,500 |
| 2022/08/15 | 1,868 | 1,870 | 1,864 | 1,866 | -2 | -0.1% | 1,700 |
| 2022/08/12 | 1,874 | 1,874 | 1,860 | 1,868 | +2 | +0.1% | 3,300 |
| 2022/08/10 | 1,855 | 1,866 | 1,854 | 1,866 | +12 | +0.6% | 1,500 |
| 2022/08/09 | 1,855 | 1,855 | 1,854 | 1,854 | -1 | -0.1% | 1,200 |
| 2022/08/08 | 1,854 | 1,867 | 1,854 | 1,855 | -5 | -0.3% | 3,000 |
| 2022/08/05 | 1,858 | 1,868 | 1,858 | 1,860 | +2 | +0.1% | 1,700 |
| 2022/08/04 | 1,873 | 1,873 | 1,853 | 1,858 | -2 | -0.1% | 8,600 |
| 2022/08/03 | 1,880 | 1,882 | 1,860 | 1,860 | -7 | -0.4% | 5,000 |
| 2022/08/02 | 1,880 | 1,880 | 1,866 | 1,867 | -13 | -0.7% | 7,900 |
| 2022/08/01 | 1,886 | 1,886 | 1,865 | 1,880 | +18 | +1% | 8,900 |
| 2022/07/29 | 1,868 | 1,874 | 1,862 | 1,862 | -5 | -0.3% | 4,700 |
| 2022/07/28 | 1,875 | 1,885 | 1,867 | 1,867 | -1 | -0.1% | 3,700 |
| 2022/07/27 | 1,861 | 1,880 | 1,861 | 1,868 | -25 | -1.3% | 12,400 |
| 2022/07/26 | 1,885 | 1,894 | 1,880 | 1,893 | +11 | +0.6% | 3,500 |
| 2022/07/25 | 1,878 | 1,886 | 1,870 | 1,882 | +12 | +0.6% | 5,400 |
| 2022/07/22 | 1,875 | 1,878 | 1,868 | 1,870 | -5 | -0.3% | 7,300 |
| 2022/07/21 | 1,870 | 1,878 | 1,867 | 1,875 | -2 | -0.1% | 2,100 |
| 2022/07/20 | 1,872 | 1,880 | 1,871 | 1,877 | +9 | +0.5% | 2,000 |
| 2022/07/19 | 1,887 | 1,887 | 1,868 | 1,868 | -6 | -0.3% | 1,500 |
| 2022/07/15 | 1,890 | 1,890 | 1,874 | 1,874 | -9 | -0.5% | 1,300 |
| 2022/07/14 | 1,872 | 1,891 | 1,872 | 1,883 | +13 | +0.7% | 1,500 |
| 2022/07/13 | 1,875 | 1,889 | 1,870 | 1,870 | -5 | -0.3% | 2,500 |
| 2022/07/12 | 1,871 | 1,894 | 1,871 | 1,875 | -5 | -0.3% | 2,600 |
| 2022/07/11 | 1,896 | 1,898 | 1,865 | 1,880 | +15 | +0.8% | 5,900 |
| 2022/07/08 | 1,896 | 1,896 | 1,860 | 1,865 | -1 | -0.1% | 11,300 |
| 2022/07/07 | 1,868 | 1,878 | 1,866 | 1,866 | ±0 | ±0% | 1,700 |
| 2022/07/06 | 1,869 | 1,876 | 1,866 | 1,866 | -7 | -0.4% | 2,700 |
| 2022/07/05 | 1,883 | 1,896 | 1,866 | 1,873 | -9 | -0.5% | 4,800 |
| 2022/07/04 | 1,897 | 1,897 | 1,874 | 1,882 | +8 | +0.4% | 1,700 |
| 2022/07/01 | 1,874 | 1,875 | 1,874 | 1,874 | ±0 | ±0% | 2,100 |
| 2022/06/30 | 1,898 | 1,898 | 1,874 | 1,874 | -9 | -0.5% | 4,400 |
| 2022/06/29 | 1,915 | 1,915 | 1,883 | 1,883 | -32 | -1.7% | 16,000 |
| 2022/06/28 | 1,910 | 1,930 | 1,902 | 1,915 | +6 | +0.3% | 5,500 |
| 2022/06/27 | 1,950 | 1,950 | 1,905 | 1,909 | +5 | +0.3% | 8,100 |
| 2022/06/24 | 2,011 | 2,011 | 1,864 | 1,904 | -96 | -4.8% | 38,000 |
| 2022/06/23 | 1,903 | 2,170 | 1,898 | 2,000 | +129 | +6.9% | 81,200 |
| 2022/06/22 | 1,878 | 1,881 | 1,871 | 1,871 | -7 | -0.4% | 2,800 |
| 2022/06/21 | 1,870 | 1,894 | 1,861 | 1,878 | +8 | +0.4% | 5,000 |
| 2022/06/20 | 1,876 | 1,876 | 1,870 | 1,870 | -6 | -0.3% | 1,300 |
| 2022/06/17 | 1,888 | 1,891 | 1,876 | 1,876 | -19 | -1% | 4,500 |
| 2022/06/16 | 1,899 | 1,900 | 1,890 | 1,895 | +6 | +0.3% | 1,700 |
551～
600
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ティムス | 20,500円 | - | - | 0.00% | - | 2.78倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補品を香港拠点ジーシンに導出 |
| ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
